On top of that, we could save the anxiety and cost of unnecessary biopsies for false positives.
Women are required or recommended to take this test every few years, so imagine the multiplicative effect of that.
Note that this test is useful for ovarian cancer recurrence test too.
Ann: Cleo Commences US Regulatory Process with FDA, page-16
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.015(4.29%) |
Mkt cap ! $29.78M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $41.12K | 112.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 4103 | 1 |
View Market Depth
| Last trade - 15.58pm 28/10/2024 (20 minute delay) ? |
| COV (ASX) Chart |